Skip to main content

Biotech Claim Drafting-Comparison between USPTO and EPO

Original Air Date 10.4.2023

The name of the game is the claim. Claim drafting is one of the foundational skills of every patent practitioner focusing on patent prosecution. While building global patent portfolios becomes more and more important to client’s businesses nowadays, knowing the nuances between practices in different jurisdictions is a key to procuring quality patent protection.

This webinar takes a comparative approach to discuss claim drafting from the perspective of European practices and US practices. We invite experts practicing in the respective regions to share their insights. The webinar is being jointly hosted by the IP Practice in Europe Committee and the Patent Agents Committee and comprises two meetings in series. Part I of this webinar, held on October 4th, 2023, will be centered on biology-related and chemistry-related fields covering claim scope and inventive steps, clarity vs. sufficiency, and eligible subject matters in these two regions.

Part II of the webinar will be held on November 9th, 2023, focusing on software patents.

Presented By:
Moderator: Wade Lin, W&A Intellectual Property Law
Speakers: Susan Kirsch, Carpmaels & Ransford & Roshni Chintalapati, CRISPR Therapeutics



AIPLA is an approved provider by most jurisdictions requiring CLE. Each program requires individual jurisdiction approval, and each jurisdiction has different approval guidelines and time frames so programs may not be pre-approved for CLE. Program accreditation is sought in all attendee requested jurisdictions and may be available for up to one year after the original air date. Specialized credits (Ethics, Elimination of Bias, Diversity, Equity & Inclusion, Technology, etc.) approval varies by jurisdiction. CLE reporting and/or certificates of attendance may take up to 4 weeks for processing. For information on CLE accreditation and processing, please contact the AIPLA CLE Department at cle@aipla.org.